Key Points {#d29e350}
==========

Hazardous alcohol use is increased in persons at risk for HIV infection and among those with HIV infection. Alcohol use increases the risk of HIV acquisition through risky sexual practices.Alcohol use is associated with decreased adherence to antiretroviral therapy resulting in HIV transmission and in progression of HIV infection to AIDS. In addition, alcohol use may promote progression of HIV disease through deleterious effects on the immune system.Alcohol use is associated with complications of HIV infection including cardiovascular and pulmonary conditions. Liver disease, in particular, is exacerbated by alcohol use, which promotes progression to cirrhosis, hepatocellular carcinoma, and death. These effects are more common in persons coinfected with HIV and chronic hepatitis C or B virus.Intervention studies to reduce alcohol use in populations with HIV or at risk of HIV are clearly important, but studies have had variable results.There may be no safe level of alcohol use in HIV infection.

Importance of Alcohol Use in HIV/AIDS {#Sec1}
=====================================

Globally, there are over 33 million persons living with HIV/AIDS resulting in 1.8 million deaths annually. While the rate of HIV transmission is slowing, it is estimated that 2.6 million new infections occur yearly \[[@CR1]\]. In the United States, there are approximately 1.2 million living with HIV/AIDS, with 50,000 new HIV infections and 17,000 deaths from the disease annually \[[@CR2]\]. For those who can obtain effective antiretroviral therapy (ART), HIV/AIDS has become a chronic disease with life expectancies over 30 years \[[@CR3]\]. Research in the last 10 years has revealed the importance of alcohol in the HIV/AIDS epidemic. Alcohol use, in moderate or hazardous amounts, has been associated with increased acquisition of HIV infection, progression of HIV infection, deleterious effects on HIV treatment, and acceleration in the comorbidities of HIV infection \[[@CR4]--[@CR9]\]. Yet alcohol remains the "forgotten drug" of the HIV/AIDS epidemic \[[@CR10]\].

Alcohol has a complex relationship with HIV acquisition. Risky sexual behaviors, among heterosexuals or among men who have sex with men (MSM), that promote HIV transmission are increased in the setting of alcohol These include increased frequency of sexual encounters with new or anonymous partners and reduced condom use \[[@CR11], [@CR12]\]. Attention to the locations and clientele where alcohol is served \[[@CR13]\] has led to the development of an "ecological epidemiology" of the interplay of multiple risk factors around HIV transmission \[[@CR14]\].

Once infected with HIV, alcohol use is associated with progression of HIV infection from asymptomatic infection, to symptomatic AIDS with declining immune function measured by low CD4 T-cell counts (\<200 cells/mm \[[@CR3]\]) in the blood, to death from wasting or an opportunistic infection. Again, the relationship between alcohol use and progression of HIV infection is multifaceted. Hazardous drinking has been associated with delayed testing and treatment for HIV infection \[[@CR12], [@CR15], [@CR16]\], poor adherence to ART therapy \[[@CR6], [@CR17]\], and increased HIV viral replication and shedding \[[@CR18]--[@CR20]\]. Simian immunodeficiency virus (SIV) infection in monkey models has confirmed findings that regular intake of alcohol leads to more rapid progression of disease, weight loss, and death \[[@CR21]--[@CR24]\].

Alcohol use also complicates the care of persons with HIV infection. Not only is adherence to ART decreased, but drug interactions between alcohol and specific ART medications may increase the toxicity of therapy \[[@CR25]\]. HIV infection has numerous comorbidities including coexisting infections such as chronic viral hepatitis or tuberculosis as well as progressive organ dysfunction involving the liver, cardiovascular system, neurological dysfunction, or pulmonary disease. Concurrent alcohol use may have a deleterious effect on any of these conditions \[[@CR26]--[@CR30]\]. Thus, the management of alcohol misuse is central to control and treatment of HIV/AIDS. This chapter summarizes recent research on the effects of alcohol on HIV infection.

Epidemiology of Alcohol Use in HIV/AIDS {#Sec2}
=======================================

Epidemiologic studies of alcohol use in HIV infection inconsistently define alcohol intake and problem drinking. Many studies categorize alcohol intake as "none," "moderate" drinking (ranging from any alcohol intake to daily intake over the period studied), and "hazardous" drinking (including regular daily intake or binge drinking and may or may not include a diagnosed alcohol disorder). In addition, the studies screening for alcohol disorders use different criteria including the CAGE questions, AUDIT questionnaire, self-reported drinking, or a physician's report of an alcohol disorder \[[@CR31]\]. Thus, varying methodology and study population selection will greatly influence the results from studies of alcohol use in HIV.

Acquisition of HIV {#Sec3}
------------------

Alcohol use, whether moderate or hazardous, daily or binge drinking pattern, increases the risk of acquiring HIV \[[@CR12], [@CR32]\]. Drinking alcohol is associated with an increased number of sexual encounters with new, anonymous, or high-risk partners \[[@CR11], [@CR12], [@CR33]\]. Alcohol use has also been shown to increase the risk of having unprotected intercourse as well as of acquiring a sexually transmitted disease, which in itself, predisposes to HIV infection through open sores \[[@CR12], [@CR34]--[@CR38]\]. Stein et al. found that hazardous drinkers were 5.6 times more likely to have multiple partners and/or unprotected sex than nonhazardous drinkers \[[@CR39]\].

The importance of alcohol as a risk factor for HIV infection has been demonstrated in all at-risk groups including heterosexual men \[[@CR4]\], MSM \[[@CR37], [@CR38], [@CR40], [@CR41]\], adolescents \[[@CR34], [@CR40]\], women \[[@CR42], [@CR43]\], and drug users \[[@CR44]--[@CR46]\]. Stueve showed that urban adolescents who use alcohol engage in high-risk sexual behaviors including multiple partners and unprotected sex, predisposing them to HIV infection at an early age \[[@CR34]\]. Women may be particularly affected by alcohol use since even if they themselves abstain, they are at increased risk of HIV based on the alcohol intake of their male partner promoting sexual violence and coercion \[[@CR43], [@CR47]\].

The association of alcohol use with HIV transmission has been well documented by a number of studies in sub-Saharan Africa \[[@CR11], [@CR32], [@CR47]\], which has one of the highest burdens of HIV infection and comprises over half of the persons infected with HIV worldwide \[[@CR1]\]. Alcohol use is higher in men and women at risk for HIV and is associated with increased sexual risk practices in Africa \[[@CR48]\]. Even low amounts of alcohol use in women (e.g., one drink in the last month) were associated with higher risk of HIV infection \[[@CR49]\]. In a meta-analysis of 11 studies from Africa, the odds ratio of having HIV was 1.57 for drinkers and 2.04 for problem drinkers compared to nondrinkers, when controlled for other HIV risk factors \[[@CR32]\]. Kalichman has shown that strategies for HIV risk reduction in these settings work best through interventions targeted at decreasing alcohol use \[[@CR50]\].

Similarly, in India, risk behaviors favoring the spread of HIV are rare among men in household sampling studies (\<4%) but high (70%) among men surveyed in wine shops (street shops selling liquor) \[[@CR51]\]. Other studies have confirmed this association, which is particularly important in India where 80% of HIV is ascribed to heterosexual transmission \[[@CR52]\]. While few women in India drink alcohol (compared to men), women may be at risk due to their husband's or male partners' drinking habits \[[@CR53], [@CR54]\]. In the Yunnan province of China, where the epidemiology of HIV has been well studied, spread of HIV has begun to shift from intravenous drug use (IDU) to sexual transmission \[[@CR55]\]. This suggests that alcohol use may also play an important role in the spread of HIV in China, but there are no data on this at present.

Social locale where alcohol is served such as bars, gay bars, beer halls, and bath houses may be a nidus of HIV transmission since persons frequenting these establishments may have a higher prevalence of HIV infection and sexually transmitted infections (STI), and sexual encounters occur frequently among the clientele \[[@CR13]\]. This may be particularly important in the transmission of HIV among gay men and female sex workers. Scribner et al. developed a model called "ecological epidemiology" that encompasses individual characteristics, social network, and the alcohol neighborhood to understand and study HIV transmission. For example, an individual who frequents a bar will be exposed to a group with multiple interrelated sexual partners and an increased prevalence of sexually transmitted disease and HIV \[[@CR14]\].

Prevalence of Alcohol Use in HIV {#Sec4}
--------------------------------

In the US population, approximately 4% meet the DSM-IV definition for alcohol abuse and 14% have had an episode of binge drinking in the last 30 days \[[@CR56], [@CR57]\]. Table [23.1](#Tab1){ref-type="table"} contrasts this with the prevalence of alcohol use among populations with HIV. There are wide apparent differences in rates of alcohol use and hazardous alcohol use due to the populations surveyed, the definitions of ­"problem" alcohol use even in the same cohort, and the methods used to determine alcohol intake.Table 23.1Prevalence of alcohol disorders in HIVDemographic groupPrevalenceReferenceNotesIn general4% alcohol abuseGrant 2004 \[[@CR56]\]US population14% binge drinking in last 30 daysNaimi 2001 \[[@CR57]\]In HIV53% any alcoholGalvan 2002 \[[@CR166]\]HCSUS, *n*  =  2,864 from 19968% heavy drinkers28% hazardous drinkersStein 2005 \[[@CR39]\]19% problem drinkingCook 2001Providence, RI, *n*  =  2625% heavy drinkersLucas 2002 \[[@CR167]\]Pittsburgh, *n*  =  212 from 19985% moderate healthConen 2009 \[[@CR64]\]risk (WHO)Baltimore, *n*  =  695, 80%nonwhite3% severe health riskSwiss HIV cohort study, *n*  =  6,323In men Veterans47% hazardous drinkingGordon 2006 \[[@CR58]\]Homeless veterans, *n*  =  88146% any alcoholBraithwaite 2005 \[[@CR6]\]VA population, 60% non9% binge drinkers24% alcohol disorderGoulet 2005 \[[@CR106]\]white20% hazardous drinkersConigliaro 2003 \[[@CR163]\] and Justice 2006 \[[@CR164]\]33% binge drinkersVA, *n*  =  25,116VA, *n*  =  881MSM17% alcohol diagnosisKraemer 2008 \[[@CR59]\]VA, *n*  =  16,04841% alcoholismLefevre 1995 \[[@CR63]\]MSM, Michigan, *n*  =  1115% heavy drinkersKleeberger 2001 \[[@CR168]\]MSM in MACS, *n*  =  539In women14--24% hazardous drinking32--48% moderate drinkingCook 2009 \[[@CR42]\]WIHS, *n*  =  2,770In Africa14% binge drinkingKalichman 2011 \[[@CR48]\]So.Africa, *n*  =  529 men in STD clinic*MSM* men who have sex with men, *WHO* world health organization definition of "moderate health risk" from alcohol consumption, *VA* veteran's association, *MACS* multicenter AIDS cohort study, *WIHS* women's interagency HIV study, *STD* sexually transmitted disease

In general, the prevalence of alcohol use disorders is several fold higher among populations with HIV infection compared to the general US population. Some of the highest prevalence rates from problem drinking are among US veterans and homeless veterans \[[@CR6], [@CR58]\]. Among the Veterans Administration (VA) population, hazardous drinking patterns are found more frequently in African-Americans (26%) than in whites (18%, *p*  \<  0.001) \[[@CR59]\]. Cook et al. determined that the prevalence of moderate and hazardous drinking among women with HIV infection was also higher than in the general US population \[[@CR42], [@CR56], [@CR57]\]. Other characteristics were associated with hazardous drinking patterns such as lower education, unemployment, nonwhite race, depression, and drug use. In both this cohort and in a VA cohort, hazardous alcohol use was associated with hepatitis C virus (HCV) infection \[[@CR42], [@CR60]\]. Among veterans with HCV infection, 35% were hazardous drinkers compared with 12% hazardous drinkers among matched controls without HCV infection \[[@CR60]\]. The increased alcohol use among IDU and the high correlation of IDU and HCV infection likely explain this finding \[[@CR46], [@CR61]\].

Alcohol Use Over Time {#Sec5}
---------------------

Alcohol intake appears to decline over time in persons with HIV infection as it does in noninfected persons with medical illness \[[@CR62]\]. Lefevre et al. examined alcohol intake in a group of 111 HIV-positive patients of a university hospital clinic, mostly MSM. In surveys repeated every 6 months for a mean follow-up of 30 months, the frequency of drinking decreased from 6.4 to 3.9 drinks/week (*p*  \<  0.001) \[[@CR63]\]. In the Swiss HIV Cohort Study, lower alcohol use was found in those who had been on ART for longer periods of time \[[@CR64]\]. Cook analyzed data from the Women's Interagency HIV study (WIHS) on 2,770 HIV-positive women followed for 11 years \[[@CR42]\]. There was a slight, approximately 5%, decrease in hazardous drinking over time but no change in the overall amount of drinking, possibly as some switched categories from hazardous to nonhazardous drinking. However, there was a significant decrease in alcohol consumption among women who were coinfected with hepatitis C and HIV from 31% with hazardous drinking patterns in 1995 to 10% in 2006.

Alcohol and HIV Progression {#Sec6}
===========================

Alcohol has been implicated in accelerating the progression of HIV disease through a number of mechanisms. Persons drinking alcohol heavily delay testing for HIV and have less connection with and retention in the health-care system \[[@CR12], [@CR15], [@CR16]\], delaying the initiation of ART. Thus, heavy alcohol use predisposes persons to late presentation in the course of infection, with high HIV viral loads, low CD4 counts, and opportunistic infections, and promotes continued spread of HIV \[[@CR45], [@CR65]\].

Adherence {#Sec7}
---------

One of the central ways alcohol intake adversely affects HIV disease is by decreasing adherence to ART. Adherence to ART is key to suppression of HIV replication, prevention of developing drug resistance, and long-term survival \[[@CR66]\]. This has been well documented among all subgroups with HIV infection \[[@CR6], [@CR64], [@CR65], [@CR67]--[@CR71]\]. While there are few studies of adherence in developing countries, one study from India confirms the association of alcohol use and risk of nonadherence or discontinuation of ART medications \[[@CR72]\]. Convincingly, there is a dose--response relationship between alcohol intake and adherence, with higher amounts of alcohol or more hazardous drinking being associated with poorer measures of adherence. Samet et al. found that the amount of alcohol consumption was the strongest predictor of adherence with highest levels of adherence being found in those abstinent from alcohol compared to moderate use or at-risk use \[[@CR70]\]. Chander et al., studying nearly 2,000 HIV-infected persons receiving care at Johns Hopkins Hospital in Baltimore, Maryland, found that adherence was 22% lower in moderate alcohol users and 54% lower in hazardous alcohol users compared to no alcohol use. Adherence was further decreased by 68% with concurrent drug use \[[@CR65]\].

There may be several reasons for lower adherence in persons who use alcohol. Drinking pattern affects the likelihood of noncompliance. Braithwaite et al., studying 2,700 members of The Veterans Administration Aging Cohort Study (VACS), found that abstainers missed ART on 2% of days. Non-binge drinkers missed medication on 4% of drinking days and post-drinking days but only on 2% of nondrinking days. Binge drinkers, in contrast, missed ART on 11% of drinking days, 5.5% of post-drinking days, and 4% on nondrinking days \[[@CR6]\]. Therefore, while medication adherence was lower on drinking days for binge and non-binge drinkers, missing medications was increased twofold among binge drinkers on days they were either not drinking or post-drinking. This suggests that ­nonadherence was also due to factors not directly related to alcohol but related to characteristics ­common among binge drinkers \[[@CR6]\]. Sankar et al. studied beliefs about alcohol and ART medication interactions in a group of African-American patients treated for HIV \[[@CR71]\]. Over three quarters of those surveyed felt that "alcohol and ART do not mix"; one-third attributed this to alcohol making ART ineffective and another third felt that alcohol made ART more toxic. In this study, participants reported purposely skipping ART doses when they drank, with light drinkers skipping 64% of the times when they drank and moderate drinkers 55% of the times. However, heavy drinkers skipped ART only 29% of the time when they drank and reported that they felt no ill effects from drinking and taking ART \[[@CR71]\]. Thus, medication adherence is determined by amount of alcohol intake, drinking pattern (binge or non-binge drinking), and beliefs about the safety of alcohol combined with ART. Issues of medication adherence and alcohol are further discussed in Chap. 18 and in a meta-analysis by Hendershot \[[@CR17]\].

Immune Function {#Sec8}
---------------

Alcoholics have increased susceptibility to bacterial infections including tuberculosis, pneumonia, and sepsis \[[@CR73]\]. In vitro studies have shown that alcohol impacts several areas of immune function, acting largely as an immunosuppressant. Alcohol decreases T-cell proliferation reducing CD4, CD8, and natural killer (NK) cell numbers \[[@CR7]\] and reduces CD8 cell responses to bacteria \[[@CR74]\]. Cell-mediated immune responses are decreased \[[@CR75]\], and myeloid dendritic cells, which are involved in antigen presentation to the immune system, are decreased in number and function with chronic alcohol ingestion \[[@CR76], [@CR77]\]. Alcohol increases expression of pro-inflammatory cytokines such as TNF-alpha \[[@CR78]\] which may enhance immune dysfunction.

Experiments by Bagasra et al. on human peripheral blood mononuclear cells (PBMC) have shown that cells from healthy persons who are infected in vitro with HIV-1 have higher levels of HIV replication when harvested after alcohol consumption \[[@CR19]\]. Enhanced HIV replication was associated with a concurrent inhibition of CD8 cells by alcohol \[[@CR18]\].

SIV infection, a macaque model for HIV, has produced evidence of the effect of alcohol on immune function and HIV replication. In rhesus macaques inoculated with SIV infection, SIV replication was 31- to 85-fold higher in monkeys with chronic alcohol ingestion compared to controls \[[@CR21]\]. SIV replication persisted in the central nervous system of alcohol-fed monkeys but was undetectable in control monkeys. Poonia et al. proposed that the mechanism of alcohol's effect on SIV replication is through its effect on intestinal lymphocytes since the small intestine is one of the most lymphocyte-rich organs. Alcohol-fed monkeys had lower numbers of CD8 cells (before and after SIV infection) and higher numbers of CD4 cells in the small intestine after SIV infection. They suggested that the 1--2 log~10~ increase in SIV replication in alcohol-fed monkeys occurs because of the increase in number of CD4 cells susceptible to SIV infection in the small intestine and reduction in CD8 cells which may control SIV replication \[[@CR22]\]. Chronic alcohol ingestion also altered the course of HIV infection with alcohol-fed monkeys having lower CD4 cell counts, lower caloric intake, higher TNF-alpha expression, and a more rapid progression to end-stage SIV disease (mean 374 days compared to 900 days in controls) \[[@CR23], [@CR24]\].

HIV Progression and Survival {#Sec9}
----------------------------

Alcohol use has been shown to affect HIV progression and survival. In the pre-HAART era, alcohol use was not associated with progression to AIDS \[[@CR79]--[@CR81]\]. However, two well-controlled, longitudinal studies since the introduction of combination ART have shown that alcohol is associated with HIV disease progression. Samet et al. studied alcohol use in 595 participants in the MACS cohort over 7 years \[[@CR82]\]. Heavy alcohol use was associated with a lower mean CD4 cell count (by ∼50 cells/mL) but not a decline in CD4 percentage or HIV viral load when adjusted for adherence. Baum et al. studied 231 HIV-positive persons followed for 2.5 years \[[@CR5]\]. Frequent alcohol users of  ≥  2 drinks/day were almost 3 times more likely to develop a CD4 count  ≤  200 cells/mL, which is an AIDS-defining event. This effect was particularly marked in alcohol users not on ART whose risk of developing a CD4 count  ≤  200 cells/mL was nearly 8 times nondrinkers. In this study, alcohol use was associated with higher HIV viral load in those on ART but not in those without ART. These results suggest that the effect of alcohol on HIV viral load is mediated through adherence. However, the effect of alcohol in lowering absolute CD4 count rather than percentage could be influenced by the splenomegaly and secondary lymphopenia seen with alcoholism and chronic viral hepatitis \[[@CR83]\]. Moderate to heavy alcohol use has also been associated with increased HIV viral shedding in the female genital tract after controlling for plasma viral load \[[@CR20]\] suggesting that alcohol may affect HIV transmission by physiological as well as behavioral risk factors.

The VACS study has provided models for estimating the effect of alcohol on survival in HIV infection. Using data on ART adherence in the VACS cohort, Braithwaite et al. developed a model simulating survival based on levels of alcohol consumption (nondrinkers, hazardous drinkers consuming  ≥  5 drinks on drinking days, and nonhazardous drinkers) \[[@CR84]\]. The model predicted decreased survival by \>1 year in nonhazardous drinkers drinking at least once a week, 3.3 years in nonhazardous drinkers drinking daily, and up to 6.4 years in hazardous drinkers drinking daily. However, the VACS index, subsequently developed to predict decreases in life expectancy based on HIV and non-HIV characteristics, does not include a separate variable for alcohol or drug abuse beyond adjusting for severity of liver disease and coexisting HCV infection \[[@CR85]\]. In addition, a longitudinal study of changes in physical function with age in the same cohort did not show an effect of alcohol \[[@CR86]\]. Further longitudinal studies in this cohort and others should define the impact of alcohol use on survival in HIV.

Liver Disease and Other Harmful Sequelae of Alcohol in HIV {#Sec10}
==========================================================

Persons with HIV infection are particularly vulnerable to the effects of alcohol. The detrimental effects of alcohol on the immune system have been covered above, and the effects of alcohol on general health and nutrition are covered in other chapters in this book. Persons with HIV infection are at risk of poor nutritional status, and even a 3% weight loss has been associated with increased mortality \[[@CR87]--[@CR90]\]. Thus, further changes in nutritional status due to alcohol use, particularly lower body weight or micronutrient deficiencies, would exacerbate the nutritional effects of HIV \[[@CR91], [@CR92]\].

Liver Disease {#Sec11}
-------------

Approximately one-third of persons with HIV infection are coinfected with HCV, and approximately 10% have evidence of chronic hepatitis B virus (HBV) infection \[[@CR93]\]. The prevalence of HCV coinfection increases to almost 90% in those who acquired HIV from IDU. Persons with coinfection with chronic hepatitis have accelerated liver fibrosis leading to cirrhosis \[[@CR9], [@CR94]\]. In a study of liver histology of IDU who had acquired HCV infection, those with concurrent HIV infection developed cirrhosis in a mean of 6.9 years after infection compared to 23.2 years among HCV mono-infected persons (*p*  \<  0.001) \[[@CR95]\]. Persons with coinfection also have an increased risk of death from end-stage liver disease \[[@CR96]--[@CR99]\]. They are also at higher risk for drug-induced hepatotoxicity from ART \[[@CR100], [@CR101]\] which may be related to altered cytochrome metabolism with progressive liver disease \[[@CR102]\]. Other metabolic abnormalities are more common in coinfected persons including hyperglycemia, diabetes, and bacterial translocation from the small intestine to the portal system, predisposing coinfected chronic inflammation and progressive liver disease \[[@CR103]--[@CR105]\].

Hazardous alcohol use is increased in some populations with coinfection, particularly IDUs \[[@CR64], [@CR106]\]. Alcohol use further exacerbates the effect of coinfection on liver disease. Alcohol use of  \>  50 g/day is associated with increased HCV replication \[[@CR107], [@CR108]\] and progressive liver fibrosis assessed by serum markers \[[@CR109]\], transient elastometry \[[@CR110]\] or by liver biopsy \[[@CR9], [@CR111]--[@CR113]\]. Death from end-stage liver disease is also more common in coinfected persons who use alcohol \[[@CR29], [@CR30], [@CR114], [@CR115]\]. The incidence of, as well as deaths related to, hepatocellular carcinoma is also increased in those with coinfection who drink alcohol \[[@CR30], [@CR116]\]. Only one study did not find an association of alcohol use and an HCV-related severe event (including decompensated cirrhosis, hepatocellular carcinoma, or death) \[[@CR117]\], but in this cohort, only 10% consumed \>30 g of alcohol daily.

Alcohol use also contributes to metabolic abnormalities in coinfected persons. It is associated with higher rates of liver steatosis \[[@CR110]\] and drug-induced liver disease \[[@CR25], [@CR118]\]. The association of alcohol use with hepatocellular carcinoma is also discussed in Chap. 32.

The adverse effects of alcohol in coinfection argue strongly for intervention. Hazardous alcohol use is a common reason for coinfected persons not receiving treatment for HCV infection, where treatment rates may be as low as 7% \[[@CR106], [@CR119]--[@CR122]\]. Fortunately, alcohol use seems to decrease with interventions after HCV diagnosis in some populations \[[@CR123], [@CR124]\]. Treatment of chronic viral hepatitis whether due to HCV or HBV infection slows the progression of liver fibrosis \[[@CR125], [@CR126]\] and reduces the incidence of drug-induced liver disease \[[@CR127]\]. Treatment outcomes with pegylated interferon and ribavirin \[[@CR128], [@CR129]\] and with the new protease inhibitors for HCV infection should continue to improve as more coinfected persons are being enrolled in treatment \[[@CR130]\].

Cardiovascular Disease {#Sec12}
----------------------

Persons with HIV infection have an increased risk of cardiovascular disease, particularly accelerated atherosclerosis and myocardial infarction \[[@CR131]--[@CR133]\]. Cardiovascular disease is likely due to a combination of additional risk factors found in HIV infection \[[@CR26]\] including (1) chronic inflammation from HIV viral replication and subsequent immunodeficiency \[[@CR134]\], (2) the effect of chronic inflammation on serum lipid levels \[[@CR133]\], (3) the metabolic effects of certain classes of antiretroviral medications \[[@CR131], [@CR133]\], (4) increased prevalence of insulin resistance \[[@CR135]\], and (5) increased translocation of bacteria across the small intestine into the bloodstream as a result of immunodeficiency \[[@CR136]\]. Persons with HIV infection have been shown to have more rapid progression of atherosclerosis measured by intermediate markers such as carotid intima--media thickness, and this has correlated with mortality \[[@CR134], [@CR137], [@CR138]\].

Alcohol use further increases the risk of cardiovascular disease in HIV infection. Freiberg et al., studying the VACS Cohort, found that the risk of cardiovascular disease was increased (OR 1.55, 95% CI 1.07--2.23) in HIV-infected men with alcohol abuse or dependence, when controlled for cardiac risk factors, ART use, and CD4 count \[[@CR8]\]. Furthermore, HCV infection may have an independent effect in increasing the risk of cardiovascular disease (OR 4.7, 95% CI 1.7--12.7) although alcohol use does not seem to affect this relationship \[[@CR139]\]. Chapters 24 and 25 explore further the relationship of alcohol and cardiovascular disease.

Pulmonary Disease {#Sec13}
-----------------

Alcohol and HIV infection are both risk factors for pulmonary diseases. Alcoholics have increased prevalence of oropharyngeal colonization by pathogenic bacteria and an increased risk of aspiration \[[@CR140]\]. In addition, they have impaired pulmonary immune function leading to a higher incidence of pneumonia \[[@CR27], [@CR140]\]. Studies have shown that alcohol use is a risk factor for the development of pneumonia in the absence of HIV, as well as more severe, multilobar pneumonia and more virulent pathogens including *Candida*, gram-negative bacteria, and *Staphylococcus aureus* infections. This, in turn, leads to longer hospitalizations and increased mortality related to alcohol use \[[@CR141]\]. The risk for adult respiratory distress syndrome (ARDS), which has a mortality of 40--60% \[[@CR142]\], is increased three- to fourfold in those with heavy alcohol intake \[[@CR143], [@CR144]\].

Similarly, persons with HIV infection are at an increased risk of community-acquired pneumonias, including unusual pathogens such as *Pseudomonas aeruginosa \[* [@CR145]\]. HIV infection is also associated with pulmonary opportunistic infections, such as *Pneumocystis \[* [@CR146]\]. While both alcohol use and HIV infection have an increased risk of pneumonia and tuberculosis, there are no studies to date that demonstrate the interaction of these risk factors for acute pulmonary disease \[[@CR27]\]. There is suggestive literature that depletions in zinc levels or pulmonary glutathione stores may mediate impaired host defense \[[@CR27]\].

Chronic lung disease in alcoholics is largely related to associated tobacco use \[[@CR27]\]. However, persons with HIV infection have an increased risk of emphysema, lung cancer, and pulmonary hypertension, independent of smoking, and this is particularly evident in those with poorly controlled HIV infection \[[@CR147]\].

Intervention Studies on Alcohol in HIV {#Sec14}
======================================

The adverse effects of alcohol use on HIV are evident, and interventions to mitigate alcohol use among HIV-infected individuals are needed. To date, clinical studies and a few randomized controlled trials (RCTs) assessing the effectiveness of interventions have shown mixed results. In this section, we will briefly review the types of interventions that have been evaluated and discuss results from a few published trials. Interested readers can refer to recent review articles for more complete reviews of the literature \[[@CR13], [@CR148], [@CR149]\].

Many types of alcohol interventions have been tested among hazardous alcohol users with and without HIV infection. These include brief interventions as well as more intensive behavioral, social network, and medication interventions. Brief interventions, also referred to as brief motivational interviews, are typically a single session discussing the patients' alcohol use. Studies employing this type of intervention often involve exploration of the pros and cons of a patient's alcohol use, self-assessment of the patient's alcohol consumption severity, and a more formal assessment of the patient's alcohol consumption as compared to the general population \[[@CR150]\]. More extensive behavioral interventions have also been investigated, including cognitive-behavioral therapy, motivation enhancement, or 12-step programs. Each of these behavioral interventions is directly aimed at investigating personal motivation behind alcohol consumption and developing personal behavior modification strategies \[[@CR151]\]. These interventions typically require multiple sessions. In addition to individualized plans and programs for those with increased alcohol consumption, social network and structural interventions which target larger populations and communities have also been evaluated. Social network interventions have most commonly focused on employing influential community leaders to change specific behaviors or promote health-conscious decisions. These studies, often referred to as Popular Opinion Leader (POL) or peer-based model interventions, may be particularly effective in communities that are difficult for outside researchers to impact \[[@CR152]\]. Alternatively, structural interventions, which may include political and legal action, may also be effective in altering individuals' behavior and environment. Lastly, medications, such as disulfiram, naltrexone, and acamprosate, have been shown to decrease alcohol consumption via physiologic effects, including decreasing cravings or causing adverse reactions when alcohol is consumed \[[@CR149]\].

In addition to the type of alcohol intervention, there are several other factors to consider when evaluating results from clinical trials of alcohol interventions. The first is the setting in which the interventions are conducted. Interventions have been conducted in various settings including primary care clinics \[[@CR153], [@CR154]\], hospital inpatient settings \[[@CR155]\], emergent care settings \[[@CR156]\], and social settings or drinking venues (places where alcohol is served) \[[@CR13]\]. A second important factor to consider is the population being targeted, which may vary depending on severity of alcohol use (dependent vs. nondependent drinkers), geographic region, and cultural practices around drinking. A third factor to consider is the outcome that is being targeted. For example, previous trials have examined the effects of alcohol interventions on decreasing alcohol consumption, improving adherence to antiretroviral medication and/or reducing sexual risk behaviors. The combination of the type of intervention, the setting in which the intervention is implemented, the population that is being targeted, and the expected outcomes of the trial will all contribute to the success or failure of an intervention.

The published literature on RCTs of alcohol interventions among populations affected by HIV reflects the various combinations of factors described above. For example, one study targeting MSM in the USA with alcohol use disorders combined two types of interventions (motivational interviewing and peer-group education/support strategies) and examined the effects on reducing at-risk drinking and sexual risk behaviors \[[@CR157]\]. In this study, individuals receiving the combined intervention reported significantly lower number of days of drinking and number of heavy drinking days per 30-day period compared to control participants. Another study tested the effects of a brief theory-based behavioral HIV--alcohol risk-reduction intervention on sexual risk behaviors in men and women recruited from informal drinking establishments in a suburban township of Capetown, South Africa \[[@CR50]\]. The authors reported significant reductions in unprotected intercourse, increased use of condoms, and less use of alcohol before sex in the intervention group compared to controls, with the largest impacts among lighter drinkers. These two studies illustrate the success of individual counseling interventions for reducing risk behaviors around alcohol consumption among persons at risk for or living with HIV.

Other interventions among individuals with HIV who consume alcohol have targeted the outcome of antiretroviral medication adherence. In two specific studies \[[@CR151], [@CR158]\], motivational interviews and cognitive-behavioral skills training were not effective in improving long-term medication adherence. Given the importance of adherence to ART to controlling HIV infection, more research is needed to develop novel interventions targeting this outcome.

Interventions directed at alcohol-serving establishments have had mixed results. Studies have focused on popular opinion leader (POL) models, in which community-defined opinion leaders are identified and trained to help shift social norms and behaviors toward safer sexual practices \[[@CR152]\]. This type of intervention in gay bars in several US cities significantly reduced episodes of risky sexual behavior compared to control bars \[[@CR152], [@CR159], [@CR160]\]; however, when this intervention was adapted for testing in several international settings, the findings were negative in that comparable reductions in risky sexual behaviors and incidence of sexually transmitted infections were seen in both intervention and control communities \[[@CR161]\]. Another study testing the effects of a peer-based intervention on reducing episodes of unprotected sex with non-wife partners in beer halls in Zimbabwe found no difference compared to controls \[[@CR162]\].

In summary, interventions involving varied counseling approaches directed at decreasing alcohol consumption and/or risky sexual behavior appear promising in specific settings. Other areas of investigation, such as interventions aimed at improving ART adherence among alcohol users or use of medications for alcohol dependence (such as naltrexone) in HIV-infected populations, need further research. More intervention studies will help to generalize findings across different contexts and help to improve health outcomes and minimize the effects of alcohol on persons living with HIV.

Is Alcohol Use Harmful in HIV? {#Sec15}
==============================

In this chapter, we have examined the prevalence of hazardous alcohol use in HIV which is much higher than found in the general US population. Alcohol use and frequenting venues where alcohol is consumed has been shown to be an important risk factor for the acquisition of HIV infection. Understanding the complex interrelationships between individual characteristics and venues should improve our approach to prevention \[[@CR12], [@CR14]\]. The effect of alcohol on adherence to ART is well documented. There are also good laboratory models, particularly with SIV infection in macaques, to show that chronic alcohol use accelerates the progression of disease. Finally, alcohol use has deleterious effects on health, particularly related to progression of liver disease in persons with HIV/HCV coinfection.

Health-care providers may underestimate the extent of hazardous drinking among their HIV patients. A study in the VA population showed that the sensitivity for health-care providers' ability to diagnose hazardous drinking was only 22% \[[@CR163]\]. Thus far, trials of interventions to reduce hazardous drinking in populations affected by HIV have shown mixed results. The underdiagnosis of hazardous alcohol use and lack of proven, effective treatment strategies raise the question of whether there is any "safe" level of alcohol intake in HIV. Justice et al. examined the relationship of medical illness related to alcohol use in veterans with HIV infection \[[@CR164]\]. For diseases associated with alcohol use (HCV infection, hypertension, diabetes, chronic obstructive lung disease, and certain infections), there was a linear relationship between alcohol intake category (none, moderate, hazardous) and the disease. This suggests that there may be no "safe" level of alcohol intake for HIV-infected persons \[[@CR165]\]. More aggressive screening and treatment of alcohol-related disorders is clearly warranted to prevent HIV transmission and to improve treatment and outcomes of persons with HIV infection \[[@CR84]\].
